Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level

Cancer-Associated Oxidoreductase ERO1-α Drives the Production of Tumor-Promoting Myeloid-Derived Suppressor Cells via Oxidative Protein Folding

(2015) Tsutomu Tanaka et al.   JOURNAL OF IMMUNOLOGY

Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding

(2015) Kazuharu Kukita et al.   JOURNAL OF IMMUNOLOGY

miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer

(2015) Xiaoyu Zhang et al.   Oncotarget

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy

(2015) Wen Wen Xu et al.   Oncotarget

Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma

(2015) Li Ming Zhu et al.   Oncotarget

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer

(2014) Andres Redondo et al.   OncoTargets and Therapy

PD-L1 Expression in Triple-Negative Breast Cancer

(2014) E. A. Mittendorf et al.   Cancer Immunology Research

Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor for poor prognosis of breast cancer

(2013) Goro Kutomi et al.   CANCER SCIENCE

Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1α Accumulation via Increased Production of Reactive Oxygen Species

(2013) Jia Ma et al.   PLoS One

Angiogenesis-related microRNAs in colon cancer

(2012) Liu Hong et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis

(2012) Bhavna Kumar et al.   PLoS One

Perinuclear Mitochondrial Clustering Creates an Oxidant-Rich Nuclear Domain Required for Hypoxia-Induced Transcription

(2012) A.-B. Al-Mehdi et al.   Science Signaling

Total Chemical Synthesis of Biologically Active Vascular Endothelial Growth Factor

(2011) Kalyaneswar Mandal et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization

(2011) Lydia W.S. Finley et al.   CANCER CELL

GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression

(2011) L. Yang et al.   CANCER RESEARCH

Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth

(2010) H. Hashizume et al.   CANCER RESEARCH

Crystal structures of human Ero1α reveal the mechanisms of regulated and targeted oxidation of PDI

(2010) Kenji Inaba et al.   EMBO JOURNAL

A Small Molecule Inhibitor of Endoplasmic Reticulum Oxidation 1 (ERO1) with Selectively Reversible Thiol Reactivity

(2010) Jaime D. Blais et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AngiomiRs—Key regulators of angiogenesis

(2009) Shusheng Wang et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway

(2008) William G. Kaelin et al.   MOLECULAR CELL

Targeting microRNA expression to regulate angiogenesis

(2007) Angelika Kuehbacher et al.   TRENDS IN PHARMACOLOGICAL SCIENCES